EGRX Eagle Pharmaceuticals Inc
New York State Common Retirement Fund Reduces Stake in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
New York State Common Retirement Fund lowered its position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX Free Report) by 58.1% during the third quarter, according to its most recent disclosure...
Zolmax·2y ago
ClariVest Asset Management LLC Sells 9,030 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
ClariVest Asset Management LLC reduced its holdings in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX Free Report) by 28.9% in the third quarter, according to the company in its most recent Form...
Ticker Report·2y ago
Commit To Buy Eagle Pharmaceuticals At $2.50, Earn 23.6% Annualized Using Options
Investors considering a purchase of Eagle Pharmaceuticals, Inc. (EGRX) shares, but tentative about paying the going market price of 5.21/share, might benefit from considering selling puts among...
Stock Options Channel·2y ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceuticals, Inc. - EGRX
NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ( Eagle or the Company ) (NASDAQ: EGRX). Such...
Globe Newswire·2y ago
EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact...
PR Newswire·2y ago
EGRX DEADLINE TOMORROW: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important February 9 Deadline in Securities Class Action EGRX
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August...
Globe Newswire·2y ago
EGRX Investors Have Opportunity to Lead Eagle Pharmaceuticals, Inc. Securities Fraud Lawsuit
EGRX Investors Have Opportunity to Lead Eagle Pharmaceuticals, Inc. Securities Fraud Lawsuit EGRX Investors Have Opportunity to Lead Eagle Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire...
PR Newswire·2y ago
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Eagle...
Business Wire·2y ago
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company") (NASDAQ: EGRX) of a class action...
Globe Newswire·2y ago
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Eagle Pharmaceuticals Investors of a Lead Plaintiff Deadline of February 9, 2024
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Eagle Pharmaceuticals Investors of a Lead Plaintiff Deadline of February 9, 2024 SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind...
PR Newswire·2y ago